Romualdo Barroso-Sousa

14PUBLICATIONS
115CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersModels of care and place of birthMolecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 18, 2026
Treatment patterns and safety of adjuvant therapy after chemoimmunotherapy for early-stage triple-negative breast cancer: real-world data from the Neo-Real/GBECAM 0123 study.

Matheus de Oliveira Andrade, Renata Colombo Bonadio, Agustina Ipiña

|Mar 06, 2026
Clinical Impact and Clinicopathologic Correlations of Oncotype DX in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Real-World Evidence From a Large Brazilian Cohort (GBECAM 0520).

Leandro Jonata de Carvalho Oliveira, Daniella Castro Araújo, Júlio Antonio Pereira de Araújo

|Feb 23, 2026
Real-world prevalence of PD-L1 positivity in early-stage/metastatic triple-negative breast cancer: primary results and pathology insights from the global retrospective observational VANESSA study.

Corrado D'Arrigo, Sitki Tuzlali, Romualdo Barroso-Sousa

|Oct 08, 2025
Cancer Health Disparities Among Patients With Early-Stage Estrogen Receptor-Positive Breast Cancer: Impact of Public Versus Private Health Care on Diagnosis-to-Treatment Interval in Brazil.

Romualdo Barroso-Sousa, Danielle Laperche-Santos, Heloisa Resende

|May 16, 2025
Unveiling the paradigm shift: systemic treatment strategies in small, node-negative breast cancer.

Mariana Carvalho Gouveia, Mariana Scaranti, Bruna Migliavacca Zucchetti

|May 16, 2025
Clinicogenomic Characterization of Inflammatory Breast Cancer.

Nolan Priedigkeit, Beth Harrison, Robert Shue

Pageof 3

Frequent Collaborators

4 joint publications

Nancy U Lin

4 joint publications

Eric P Winer

3 joint publications

Andrea Kazumi Shimada

3 joint publications

Daniele Assad-Suzuki